Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion type Assertion NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_head.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion description "[We describe for the first time that high levels of LOXL2 are associated with decreased overall and disease-free survival in laryngeal squamous cell carcinomas, lung squamous cell carcinoma, and lymph node-negative (N(0)) breast adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion evidence source_evidence_literature NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion SIO_000772 18559498 NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion wasDerivedFrom befree-20140225 NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.
- NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_assertion wasGeneratedBy ECO_0000203 NP849159.RAPGgIgmR11b--INYj1rAbwILsU3vz2YgiHj9wfJFMhNU130_provenance.